VITA, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 17.007
EU - Europa 7.239
AS - Asia 6.383
SA - Sud America 352
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 35
AF - Africa 21
Totale 31.074
Nazione #
US - Stati Uniti d'America 16.930
CN - Cina 2.221
SG - Singapore 2.182
UA - Ucraina 1.984
IT - Italia 1.775
HK - Hong Kong 1.276
DE - Germania 902
FI - Finlandia 418
RU - Federazione Russa 411
TR - Turchia 393
GB - Regno Unito 387
IE - Irlanda 381
PL - Polonia 316
BR - Brasile 315
FR - Francia 226
IN - India 118
SE - Svezia 108
CZ - Repubblica Ceca 101
CA - Canada 56
BE - Belgio 50
NL - Olanda 46
ID - Indonesia 37
AU - Australia 36
AT - Austria 33
EU - Europa 29
IR - Iran 29
VN - Vietnam 26
ES - Italia 18
SA - Arabia Saudita 15
AR - Argentina 14
CH - Svizzera 14
LT - Lituania 14
MX - Messico 12
JP - Giappone 11
BD - Bangladesh 9
HU - Ungheria 9
GR - Grecia 8
AM - Armenia 7
EC - Ecuador 7
PH - Filippine 7
PT - Portogallo 7
IL - Israele 6
PE - Perù 6
RO - Romania 6
A1 - Anonimo 5
AE - Emirati Arabi Uniti 5
CO - Colombia 5
KG - Kirghizistan 5
MA - Marocco 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
KZ - Kazakistan 4
MU - Mauritius 4
PA - Panama 4
PK - Pakistan 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
EG - Egitto 3
IQ - Iraq 3
KR - Corea 3
LV - Lettonia 3
NO - Norvegia 3
SI - Slovenia 3
ZA - Sudafrica 3
CL - Cile 2
DK - Danimarca 2
EE - Estonia 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
TH - Thailandia 2
TJ - Tagikistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
ML - Mali 1
MS - Montserrat 1
NP - Nepal 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 31.074
Città #
Fairfield 2.179
Woodbridge 1.782
Jacksonville 1.536
Singapore 1.436
Houston 1.299
Hong Kong 1.265
Ashburn 1.138
Chandler 1.119
Cambridge 856
Seattle 839
Ann Arbor 807
Wilmington 781
Princeton 720
Nanjing 507
New York 408
Dublin 377
Brescia 359
Istanbul 356
Warsaw 312
Helsinki 271
Beijing 251
The Dalles 211
Milan 188
Nanchang 182
Des Moines 181
Moscow 160
Dearborn 154
Changsha 144
Shenyang 133
Hebei 124
Lancaster 124
Jinan 122
Boardman 118
Tianjin 118
Munich 116
San Diego 106
Rome 90
Jiaxing 80
Shanghai 79
Brno 70
Los Angeles 64
Hangzhou 62
Romola 60
London 57
Zhengzhou 54
Kunming 50
San Mateo 49
Washington 41
Toronto 38
Brussels 37
Nuremberg 35
Ningbo 33
Norwalk 33
Jakarta 32
Frankfurt am Main 31
Lanzhou 31
Augusta 30
Guangzhou 30
Haikou 30
Orange 30
San Francisco 30
Verona 29
Leawood 28
Düsseldorf 27
Olomouc 26
Taizhou 26
Dong Ket 22
Kocaeli 21
São Paulo 20
Fuzhou 18
Lappeenranta 18
Monmouth Junction 18
Taiyuan 18
Council Bluffs 17
Belo Horizonte 16
Redwood City 16
Turin 16
Ardabil 15
Bologna 14
Changchun 14
Santa Clara 12
Vienna 12
Coventry 11
Falkenstein 11
Florence 11
Gent 11
Kilburn 11
Lauterbourg 11
Mumbai 11
Palermo 11
Riyadh 11
Sydney 11
Tehran 11
Melbourne 10
Mexico City 10
Rio de Janeiro 10
Amsterdam 9
Bari 9
Cagliari 9
Hounslow 9
Totale 22.545
Nome #
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 449
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 272
Il training cognitivo nei pazienti affetti da schizofrenia 199
The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies 191
Predictors of cognitive improvement and normalization under cognitive remediation in patients with schizophrenia. 187
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 178
Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): a nationwide snapshot of the status of treatment for major depression. 169
Cognitive remediation in schizophrenia: current status and future perspectives. 168
Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care. 158
Correlates of autistic traits among patients with borderline personality disorder 158
Combined measure of smooth pursuit eye movements and ventricle-brain ratio in schizophrenic disorders. 154
Autism spectrum disorder and schizophrenia: Do they overlap? 153
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 149
Does cognitive remediation modify the use of psychiatric services and the patterns of care of patients with schizophrenia? 148
Effectiveness of different modalities of cognitive remediation on symptomatological, neuropsychological, and functional outcome domains in schizophrenia: A prospective study in a real-world setting 147
Psychiatric hospitalization rates in italy before and during covid-19: Did they change? an analysis of register data 147
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 146
A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. 145
Looking through autistic features in schizophrenia using the PANSS Autism Severity Score (PAUSS) 145
Adult Autism Subthreshold Spectrum (AdAS Spectrum): Validation of a questionnaire investigating subthreshold autism spectrum 143
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 143
Cognitive remediation in schizophrenia. 138
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review 138
Autistic traits in a sample of adult patients with schizophrenia: prevalence and correlates 137
Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome. 135
X-linked mental retardation with Marfanoid habitus. First report of four italian patients. 135
Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia 134
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 133
Effects of cognitive remediation therapy on neurocognition and negative symptoms in schizophrenia: an Italian naturalistic study 133
Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: A prospective controlled study in a real-world setting. 132
Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis. 132
Adherence to antipsychotics in schizophrenia. 130
A linkage study of schizophrenia to markers within Xp11 near the MAOB gene. 130
A roadmap to disentangle the molecular etiology of schizophrenia 129
Factors Associated With Brain Heterogeneity in Schizophrenia 129
Tools for measuring clinical effectiveness. 127
Autistic symptoms predict social cognitive performance in patients with schizophrenia 123
Antipsychotic drugs v. barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysis 123
Factors affecting antipsychotic drug discontinuation in the treatment of schizophrenia: Evidence from a naturalistic, retrospective, 18-month follow-up study. 122
Cognitive remediation in the early course of schizophrenia: a critical review. 122
Virological and immunological study of schizophrenic patients in relation to CT scan abnormality. 122
Season of birth and cerebral ventricular enlargement in schizophrenia 121
Age of onset in familial schizophrenia. 120
HLA-DR antigens in schizophrenia. 119
At-risk gambling in patients with severe mental illness. Prevalence and associated features. 119
Attitudes of Italian Psychiatrists Toward the Evaluation of Physical Comorbidities and Sexual Dysfunction in Patients With Schizophrenia. Implications for Clinical Practice 119
Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessment. 118
Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies 118
A reconsideration of the relationship between cerebral structural abnormalities and family history of schizophrenia. 117
Non pharmacological strategies to enhance adherence and continuity of care in schizophrenia. 117
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study 117
A genome-wide search for schizophrenia susceptibility genes. 116
Brain morphology in schizophrenic disorder: prevalence and correlates of diffuse (cortical and subcortical) brain atrophy. 116
Patterns of Structural MRI Abnormalities in Deficit and Nondeficit Schizophrenia. 116
Time course of cerebral ventricular enlargement in schizophrenia supports the hypothesis of its neurodevelopmental nature. 116
Cortical atrophy in schizophrenia: prevalence and associated features 115
Cognitive remediation in schizophrenia: background, techniques, evidence of efficacy and perspectives 115
Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report 115
Evidence for linkage to psychosis and cerebral asymmetry (relative hand skill) on the X chromosome 114
Early life events and affective disorder revisited. 112
Longitudinal studies of brain morphology and outcome of schizophrenic disorder 112
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 112
Cognitive remediation in schizophrenia: a controlled study 111
CLINICAL ASSESSMENT OF COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA THROUGH THE SCHIZOPHRENIA COGNITION RATING SCALE: A VALIDATION STUDY IN THE ITALIAN POPULATION 110
Lack of evidence for linkage to chromosomes 13 and 8 for schizophrenia and schizoaffective disorder 110
Il rimedio cognitivo nelle psicosi: principi e metodi. 109
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 109
Uso della PET e della SPECT in psichiatria 109
The effects of antipsychotic treatment on cerebral structure and function in schizophrenia. 109
Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. 108
COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study. 108
Structural brain abnormalities in bipolar disorder: what meta-analyses tell us 108
Persistence of effectiveness of cognitive remediation interventions in schizophrenia: A 1-year follow-up study. 108
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial 108
Factors related to different reasons for antipsychotic drug discontinuation in the treatment of schizophrenia: A naturalistic 18-month follow-up study. 107
Il training cognitivo della Terapia Psicologica Integrata (IPT): presupposti e descrizione. 107
Magnetic resonance imaging findings in schizophrenia: relationships with language and thought disorders, symptomatology and cognitive performance. 107
Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies 107
Hippocampal and amygdala volume reductions in first-episode schizophrenia. 106
CT scan abnormalities and outcome of chronic schizophrenia 106
Qualitative MRI findings in patients with schizophrenia: a controlled study. 105
Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. 105
La cognitività sociale nella schizofrenia: modelli interpretativi e strategie di intervento 105
Failure to find a chromosome 18 pericentric linkage in families with schizophrenia 105
Cerebral ventricular abnormalities in schizophrenia: evidence of their early origin and stability over time. 105
Male siblings with schizophrenia share alleles at the androgen receptor above chance expectation. 105
Well-being in patients with schizophrenia, mood and personality disorders attending psychiatric services in the community. A controlled study 105
Language and thought disorder in schizophrenia: brain morphological correlates. 104
Brain structural effects of antidepressant treatment in major depression 104
Neuromorphological correlates of mood disorders: focus on cerebral ventricular enlargement. 104
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma 104
Psychopharmacological treatment of cognitive deficits in Schizophrenia and mood disorders 104
Real-world effectiveness of long acting aripiprazole: Treatment persistence and its correlates in the Italian clinical practice 104
Cerebral ventricular enlargement as a generalized feature of schizophrenia: a distribution analysis on 502 subjects. 102
Outcome of positive and negative symptoms during neuroleptic therapy in schizophrenia 102
Poor adherence to antipsychotic medication in people with schizophrenia: diffusion, consequences and contributing factors. 101
The Implementation of Evidence-Based Psychiatric Rehabilitation: Challenges and Opportunities for Mental Health Services 101
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. 100
Psychosocial Rehabilitation in Italy Today 100
Clinical-biological patterns and prediction of response to haloperidol in schizophrenia 100
Totale 12.809
Categoria #
all - tutte 175.942
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 175.942


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020833 0 0 0 0 0 0 0 0 0 0 421 412
2020/20214.794 111 581 191 497 185 580 143 534 541 572 604 255
2021/20222.574 185 463 58 150 39 124 123 200 136 284 188 624
2022/20233.141 411 30 31 329 246 798 28 366 550 54 153 145
2023/20243.083 207 90 249 209 167 558 109 84 634 81 58 637
2024/20255.650 93 98 144 820 866 631 594 238 893 711 562 0
Totale 31.856